James Allred, MD
Clinical Cardiac Electrophysiology · Greensboro, NCNPI 1669583316
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Biosense Webster, Inc. at 29.5% of the total. Reporting peaked in 2019 at $75,679 and has fallen 96.3% since, to $2,793 in 2025. Among clinical cardiac electrophysiology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 466 payments — averaging $393.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$54K
- Medtronic$45K
- Johnson & Johnson$28K
- Sanofi-aventis U.S. LLC$22K
- Cvrx, Inc.$13K
- Abbott$12K
- plus $9K from 26 others
Across 133 payments — averaging $12,566 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cvrx, Inc.$1.3M
- Medtronic$339K
- Abbott$36K
What the payments were for
- Consulting fees$94,46551%
- Speaking & faculty fees$62,33034%
- Travel & lodging$15,1178%
- Food & beverage$11,6676%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 40 | $54,167 |
| Medtronic(2 entities) | 154 | $44,648 |
| Johnson & Johnson | 51 | $28,190 |
| Sanofi-aventis U.S. LLC | 13 | $22,312 |
| Cvrx, Inc. | 25 | $13,405 |
| Abbott | 90 | $12,209 |
| Medical Device Business Services, Inc. | 5 | $5,209 |
| Altathera Pharmaceuticals LLC | 1 | $1,500 |
| Boston Scientific | 9 | $459 |
| Biotronik Inc. | 6 | $330 |
| Novartis | 14 | $224 |
| Pfizer | 12 | $180 |
| Amgen | 9 | $169 |
| Boehringer Ingelheim | 7 | $108 |
| E.r. Squibb & Sons, L.L.C. | 5 | $68 |
| Merck | 3 | $63 |
| Irhythm Technologies, Inc. | 4 | $57 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Mayne Pharma Commercial LLC | 1 | $35 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $32 |
| Portola Pharmaceuticals, LLC | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Bard Peripheral Vascular, Inc. | 1 | $16 |
| Cardiovascular Systems Inc. | 1 | $15 |
| Teleflex LLC | 1 | $14 |
| AstraZeneca | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $13 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $12 |
| Atricure, Inc. | 1 | $12 |
| Chiesi USA, Inc. | 1 | $12 |
| Cardiva Medical, Inc. | 1 | $11 |
| Organon | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3 System$31,650
- XARELTO$27,404
- Carto 3$26,819
- Barostim Neo System$12,971
- MULTAQ$11,420
- Reveal LINQ$7,418
- AVEIR$4,375
- DISEASE STATE$3,970
- Carto Smarttouch$3,150
- Arctic Front$2,727
- GALLANT$2,375
- Sotalol Hydrochloride$1,500
- LINQ II$226
- Micra$161
- Claria MRI$155
- Acticor 7 VR-T DX$139
- EMBLEM$136
- PulseSelect$131
- Nanostim Leadleas Pacemaker$113
- CareLink Express$112
How this compares
$183,579 in reported general payments places this provider in the 95th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.
See all clinical cardiac electrophysiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 81 | $88,775 |
| XareltoRivaroxaban | 54 | $53,290 |
| Repatha SureclickEvolocumab | 18 | $9,648 |
| Dofetilide | 21 | $2,419 |
| Metoprolol Succinate | 35 | $396 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 17 | $309 |
| Losartan Potassium | 13 | $183 |
| Metoprolol Tartrate | 20 | $154 |
| Atorvastatin Calcium | 11 | $146 |
| Amiodarone Hcl | 15 | $112 |
| Spironolactone | 14 | $77 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $180 | $88,77581 claims |
| Johnson & JohnsonXarelto | $28,190 | $53,29054 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.
Other clinical cardiac electrophysiology in Greensboro
- Matthew CarlisleGreensboro$41K
- Joshua ParkerGreensboro$19K
- Michael ManogueAsheville$230K
- Daniel FriedmanDurham$196K
- John RhynerAsheville$168K
- Gregory HarrisGreenville$164K
- John CatanzaroGreenville$159K
- Kevin ManochaRaleigh$146K
- Albert SunDurham$138K
- Manish JainConcord$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.